2026 Summer Intern - Antibody Engineering jobs in United States
cer-icon
Apply on Employer Site
company-logo

Genentech · 1 week ago

2026 Summer Intern - Antibody Engineering

Genentech is a leading biotechnology company that focuses on advancing biologics. They are seeking a Summer Intern for their Antibody Engineering team to drive experiments, characterize antibodies, and present findings to colleagues.

BiotechnologyLife ScienceManufacturing
check
Comp. & Benefits
check
H1B Sponsor Likelynote

Responsibilities

Drive experiments aimed at advancing new antibody-based technologies
Characterize biochemical properties of antibodies
Test their activities in functional assay
Present the results of the effort to colleagues in the department

Qualification

Antibody engineeringBiochemical characterizationCell cultureBiacore analysisCommunication skillsCollaboration skillsInterpersonal skills

Required

Must be pursuing a Master's Degree (enrolled student)
Must be pursuing a PhD (enrolled student)
Required Majors: Protein Sciences, Biochemistry, Pharmaceutical Sciences or related field

Preferred

Excellent communication, collaboration, and interpersonal skills
Complements our culture and the standards that guide our daily behavior & decisions: Integrity, Courage, and Passion
Experience with Cell culture, Antibody engineering/characterization and Biacore analysis

Benefits

Paid holiday time off benefits

Company

Genentech

company-logo
Genentech is a biotechnology research company that specializes in genetic testing and personalized medicines.

H1B Sponsorship

Genentech has a track record of offering H1B sponsorships. Please note that this does not guarantee sponsorship for this specific role. Below presents additional info for your reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (167)
2024 (148)
2023 (150)
2022 (178)
2021 (121)
2020 (158)

Funding

Current Stage
Public Company
Total Funding
unknown
2009-03-26Acquired
1999-07-20IPO
1976-01-01Series Unknown

Leadership Team

leader-logo
Ashley Magargee
Chief Executive Officer
linkedin
leader-logo
Michael Laird
Vice President, Global MSAT Drug Substance Biologics Technology and Commercial Products Support
linkedin
Company data provided by crunchbase